171 related articles for article (PubMed ID: 15359571)
21. Dual ionic interaction system based on polyelectrolyte complex and ionic, injectable, and thermosensitive hydrogel for sustained release of human growth hormone.
Park MR; Seo BB; Song SC
Biomaterials; 2013 Jan; 34(4):1327-36. PubMed ID: 23149013
[TBL] [Abstract][Full Text] [Related]
22. Stability of human growth hormone in supercritical carbon dioxide.
Kelly CA; Howdle SM; Naylor A; Coxhill G; Tye LC; Illum L; Lewis AL
J Pharm Sci; 2012 Jan; 101(1):56-67. PubMed ID: 21905036
[TBL] [Abstract][Full Text] [Related]
23. Sustained-release of Cyclosporin A pellets: preparation, in vitro release, pharmacokinetic studies and in vitro-in vivo correlation in beagle dogs.
Jiang D; Zeng J; Zhu Y; Zhou G; Deng W; Xu X; Yu J
Drug Dev Ind Pharm; 2016; 42(7):1174-82. PubMed ID: 26555803
[TBL] [Abstract][Full Text] [Related]
24. Controlled release of protein drugs from newly developed amphiphilic polymer-based microparticles composed of nanoparticles.
Kakizawa Y; Nishio R; Hirano T; Koshi Y; Nukiwa M; Koiwa M; Michizoe J; Ida N
J Control Release; 2010 Feb; 142(1):8-13. PubMed ID: 19804802
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer.
Santoveña A; Fariña JB; Llabrés M; Zhu Y; Dannies P
Int J Pharm; 2010 Mar; 388(1-2):175-80. PubMed ID: 20060456
[TBL] [Abstract][Full Text] [Related]
26. Properties of a Stable and Sustained-Release Formulation of Recombinant Human Parathyroid Hormone (rhPTH) with Chitosan and Silk Fibroin Microparticles.
Lv BH; Tan W; Zhu CC; Shang X; Zhang L
Med Sci Monit; 2018 Oct; 24():7532-7540. PubMed ID: 30345994
[TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetic and pharmacodynamic evaluation between a new biosimilar and reference recombinant human growth hormone.
Toffoletto O; Afiune J; Thiemann JE; Khandave SS; Patel S; Rodrigues DG
Growth Horm IGF Res; 2016; 30-31():31-36. PubMed ID: 27657985
[TBL] [Abstract][Full Text] [Related]
28. An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits.
Bouriche S; Alonso-García A; Cárceles-Rodríguez CM; Rezgui F; Fernández-Varón E
BMC Vet Res; 2021 Sep; 17(1):315. PubMed ID: 34563196
[TBL] [Abstract][Full Text] [Related]
29. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system.
Leitner VM; Guggi D; Krauland AH; Bernkop-Schnürch A
J Control Release; 2004 Nov; 100(1):87-95. PubMed ID: 15491813
[TBL] [Abstract][Full Text] [Related]
30. Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs.
Shin S; Kim TH; Jeong SW; Chung SE; Lee DY; Kim DH; Shin BS
PLoS One; 2019; 14(5):e0216875. PubMed ID: 31091273
[TBL] [Abstract][Full Text] [Related]
31. Preparative alkaline urea gradient PAGE: application to purification of extraordinarily-stable disulfide-linked homodimer of human growth hormone.
Grigorian AL; Bustamante JJ; Muñoz J; Aguilar RM; Martinez AO; Haro LS
Electrophoresis; 2007 Nov; 28(21):3829-36. PubMed ID: 17922505
[TBL] [Abstract][Full Text] [Related]
32. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
33. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
[TBL] [Abstract][Full Text] [Related]
34. Impact of release characteristics of sinomenine hydrochloride dosage forms on its pharmacokinetics in beagle dogs.
Sun J; Shi JM; Zhang TH; Gao K; Mao JJ; Li B; Sun YH; He ZG
World J Gastroenterol; 2005 Aug; 11(29):4547-51. PubMed ID: 16052686
[TBL] [Abstract][Full Text] [Related]
35. Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres.
Costantino HR; Johnson OL; Zale SE
J Pharm Sci; 2004 Oct; 93(10):2624-34. PubMed ID: 15349971
[TBL] [Abstract][Full Text] [Related]
36. In vivo residence duration of human growth hormone loaded in nanogels comprising cinnamoyl alginate, cinnamoyl Pluronic F127 and cinnamoyl poly(ethylene glycol).
Yoon DY; Kim JC
Int J Pharm; 2016 Jul; 509(1-2):229-236. PubMed ID: 27242314
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human growth hormone-binding protein fails to enhance the in vivo bioactivity of human growth hormone in normal rats.
Tzanela M; Wagner C; Tannenbaum GS
Endocrinology; 1997 Dec; 138(12):5316-24. PubMed ID: 9389516
[TBL] [Abstract][Full Text] [Related]
38. Expression, purification and characterization of the authentic form of human growth hormone receptor antagonist G120R-hGH obtained in Escherichia coli periplasmic space.
Menezes ACSC; Suzuki MF; Oliveira JE; Ribela MTCP; Furigo IC; Donato J; Bartolini P; Soares CRJ
Protein Expr Purif; 2017 Mar; 131():91-100. PubMed ID: 28013084
[TBL] [Abstract][Full Text] [Related]
39. Somatropin and its variants: structural characterization and methods of analysis.
Bayol A; Bristow A; Charton E; Girard M; Jongen P
Pharmeuropa Bio; 2004 Dec; 2004(1):35-45. PubMed ID: 15659284
[TBL] [Abstract][Full Text] [Related]
40. [Preparation of in situ gel systems for the oral delivery of ibuprofen and its pharmacokinetics study in beagle dogs].
Wu RL; Zhao CS; Xie JW; Yi SL; Song HT; He ZG
Yao Xue Xue Bao; 2008 Sep; 43(9):956-62. PubMed ID: 19048790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
